Myeloid differentiation factor‐2 activates monocytes in patients with dilated cardiomyopathy-Reference-Cited by-同舟云学术

Myeloid differentiation factor‐2 activates monocytes in patients with dilated cardiomyopathy

Published:2022-06-29 Issue:1 Volume:167 Page:40-53
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Feldtmann Rico¹²^ORCID,Kümmel Andreas¹²,Chamling Bishwas¹²,Strohbach Anne¹²,Lehnert Kristin¹²,Gross Stefan¹²,Loerzer Lisa¹²,Riad Alexander³,Lindner Diana⁴⁵,Westermann Dirk⁴⁵,Fielitz Jens¹²,Dörr Marcus¹²,Felix Stephan B.¹²

Affiliation:

1. Department of Internal Medicine B, Cardiology University Medicine Greifswald Greifswald Germany

2. DZHK (German Centre for Cardiovascular Research) Partner Site Greifswald Greifswald Germany

3. DRK‐Krankenhaus Teterow gGMBH, Internal Medicine Teterow Germany

4. Department of Cardiology University Heart and Vascular Center Hamburg Germany

5. DZHK (German Centre for Cardiovascular Research) Partner Site Hamburg/Kiel/Lübeck Hamburg Germany

Funder

Deutsche Forschungsgemeinschaft

Deutsches Zentrum für Herz-Kreislaufforschung

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13490

Reference39 articles.

1. The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC

2. Variants of Toll-like Receptor 4 Predict Cardiac Recovery in Patients with Dilated Cardiomyopathy

3. The emerging role of Toll-like receptor 4 in myocardial inflammation

4. Essential role of MD-2 in LPS responsiveness and TLR4 distribution

5. Myeloid differentiation factor 2 in the heart: Bench to bedside evidence for potential clinical benefits?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-05-31

2. Immune cells and related cytokines in dilated cardiomyopathy;Biomedicine & Pharmacotherapy;2024-02

3. The Molecular Role of Immune Cells in Dilated Cardiomyopathy;Medicina;2023-07-05

4. Identification of Novel Targets for Treatment of Dilated Cardiomyopathy Based on the Ferroptosis and Immune Heterogeneity;Journal of Inflammation Research;2023-06

5. Dapagliflozin attenuates myocardial remodeling in hypertension by activating the circadian rhythm signaling pathway;Archives of Pharmacal Research;2023-02